Radiotherapy for Thymoma and Thymic Carcinoma

Hematology/Oncology Clinics of North America

Volumn 22, Issue 3, 2008, Pages 489-507

  Fuller, Clifton David ^a,b   Housman, Douglas M ^c   Thomas, Charles R ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN;

CANCER INCIDENCE; CANCER RADIOTHERAPY; COMBINATION CHEMOTHERAPY; CYTOREDUCTIVE SURGERY; HUMAN; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; THYMOMA; THYMUS CANCER; TREATMENT OUTCOME;

HUMANS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, CONFORMAL; THYMOMA; THYMUS NEOPLASMS;

EID: 44249102758     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2008.03.012     Document Type: Review

References (67)

1. Nakahara K., Ohno K., Hashimoto J., et al. Thymoma: results with complete resection and adjuvant postoperative irradiation in 141 consecutive patients. J Thorac Cardiovasc Surg 95 6 (1988) 1041-1047
2. Monden Y., Nakahara K., Iioka S., et al. Recurrence of thymoma: clinicopathological features, therapy, and prognosis. Ann Thorac Surg 39 2 (1985) 165-169
3. Awad W.I., Symmans P.J., and Dussek J.E. Recurrence of stage I thymoma 32 years after total excision. Ann Thorac Surg 66 6 (1998) 2106-2108
4. Gamondes J.P., Balawi A., Greenland T., et al. Seventeen years of surgical treatment of thymoma: factors influencing survival. Eur J Cardiothorac Surg 5 3 (1991) 124-131
5. Regnard J.F., Fourquier P., and Levasseur P. Results and prognostic factors in resections of primary tracheal tumors: a multicenter retrospective study. The French Society of Cardiovascular Surgery. J Thorac Cardiovasc Surg 111 4 (1996) 808-813 [discussion: 813-4]
6. Cowen D., Richaud P., Mornex F., et al. Thymoma: results of a multicentric retrospective series of 149 non-metastatic irradiated patients and review of the literature. FNCLCC trialists. Federation Nationale des Centres de Lutte Contre le Cancer. Radiother Oncol 34 1 (1995) 9-16
7. Wilkeins E.W., Grillo H.C., and Scannell J.G. Role of staging in prognosis and management of thymoma. Ann Thorac Surg 51 (1991) 888-892
8. Kaiser LR, Martini N. Clinical management of thymomas: The Memorial Sloan-Kettering Cancer Center experience. Thoracic surgery: frontiers and uncommon neoplasms Vol. 5. 1989;5:176-83.
9. Housman D.M., Smith B.D., Detterbeck F.C., et al. The Role Of Radiation Therapy In Malignant Thymomas: A Population-Based Study. Int J Radiat Oncol Biol Phys 66 3 Suppl (2006) S150
10. Kondo K., and Monden Y. Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. Ann Thorac Surg 76 3 (2003) 878-884 [discussion: 884-5]
11. Lucchi M., Mussi A., Ambrogi M., et al. Thymic carcinoma: a report of 13 cases. Eur J Surg Oncol 27 7 (2001) 636-640
12. Haniuda M., Morimoto M., Nishimura H., et al. Adjuvant radiotherapy after complete resection of thymoma. Ann Thorac Surg 54 2 (1992) 311-315
13. Ruffini E., Mancuso M., Oliaro A., et al. Recurrence of thymoma: analysis of clinicopathologic features, treatment, and outcome. J Thorac Cardiovasc Surg 113 1 (1997) 55-63
14. Zhu G., He S., Fu X., et al. Radiotherapy and prognostic factors for thymoma: a retrospective study of 175 patients. Int J Radiat Oncol Biol Phys 60 4 (2004) 1113-1119
15. Urgesi A., Monetti U., Rossi G., et al. Role of radiation therapy in locally advanced thymoma. Radiother Oncol 19 3 (1990) 273-280
16. Blumberg D., Port J.L., Weksler B., et al. Thymoma: a multivariate analysis of factors predicting survival. Ann Thorac Surg 60 4 (1995) 908-913 [discussion: 914]
17. Haniuda M., Miyazawa M., Yoshida K., et al. Is postoperative radiotherapy for thymoma effective?. Ann Surg 224 2 (1996) 219-224
18. Mangi A.A., Wain J.C., Donahue D.M., et al. Adjuvant radiation of stage III thymoma: is it necessary?. Ann Thorac Surg 79 6 (2005) 1834-1839
19. Mangi A.A., Wright C.D., Allan J.S., et al. Adjuvant radiation therapy for stage II thymoma. Ann Thorac Surg 74 4 (2002) 1033-1037
20. Maggi G., Casadio C., Cavallo A., et al. Thymoma: results of 241 operated cases. Ann Thorac Surg 51 1 (1991) 152-156
21. Curran Jr. W.J., Kornstein M.J., Brooks J.J., et al. Invasive thymoma: the role of mediastinal irradiation following complete or incomplete surgical resection. J Clin Oncol 6 11 (1988) 1722-1727
22. Ciernik I.F., Meier U., and Lutolf U.M. Prognostic factors and outcome of incompletely resected invasive thymoma following radiation therapy. J Clin Oncol 12 7 (1994) 1484-1490
23. Batata M.A., Martini N., Huvos A.G., et al. Thymomas: clinicopathologic features, therapy, and prognosis. Cancer 34 2 (1974) 389-396
24. Ohara K., Okumura T., Sugahara S., et al. The role of preoperative radiotherapy for invasive thymoma. Acta Oncol 29 4 (1990) 425-429
25. Sellors T.H., Thackray A.C., and Thomson A.D. Tumours of the thymus. A review of 88 operation cases. Thorax 22 3 (1967) 193-220
26. Weissberg D., Goldberg M., and Pearson F.G. Thymoma. Ann Thorac Surg 16 2 (1973) 141-147
27. Myojin M., Choi N.C., Wright C.D., et al. Stage III thymoma: pattern of failure after surgery and postoperative radiotherapy and its implication for future study. Int J Radiat Oncol Biol Phys 46 4 (2000) 927-933
28. Yagi K., Hirata T., Fukuse T., et al. Surgical treatment for invasive thymoma, especially when the superior vena cava is invaded. Ann Thorac Surg 61 2 (1996) 521-524
29. Ribet M., Voisin C., Pruvot F.R., et al. Lympho-epithelial thymomas. A retrospective study of 88 resections. Eur J Cardiothorac Surg 2 4 (1988) 261-264
30. Akaogi E., Ohara K., Mitsui K., et al. Preoperative radiotherapy and surgery for advanced thymoma with invasion to the great vessels. J Surg Oncol 63 1 (1996) 17-22
31. Masaoka A., Monden Y., Nakahara K., et al. Follow-up study of thymomas with special reference to their clinical stages. Cancer 48 11 (1981) 2485-2492
32. Okumura M., Miyoshi S., Takeuchi Y., et al. Results of surgical treatment of thymomas with special reference to the involved organs. J Thorac Cardiovasc Surg 117 3 (1999) 605-613
33. Arakawa A., Yasunaga T., Saitoh Y., et al. Radiation therapy of invasive thymoma. Int J Radiat Oncol Biol Phys 18 3 (1990) 529-534
34. Jackson M.A., and Ball D.L. Post-operative radiotherapy in invasive thymoma. Radiother Oncol 21 2 (1991) 77
35. Urgesi A., Monetti U., Rossi G., et al. Aggressive treatment of intrathoracic recurrences of thymoma. Radiother Oncol 24 4 (1992) 221-225
36. Venuta F., Rendina E.A., Longo F., et al. Long-term outcome after multimodality treatment for stage III thymic tumors. Ann Thorac Surg 76 6 (2003) 1866-1872 [discussion: 1872]
37. Uematsu M., Yoshida H., Kondo M., et al. Entire hemithorax irradiation following complete resection in patients with stage II-III invasive thymoma. Int J Radiat Oncol Biol Phys 35 2 (1996) 357-360
38. Mornex F., Resbeut M., Richaud P., et al. Radiotherapy and chemotherapy for invasive thymomas: a multicentric retrospective review of 90 cases. The FNCLCC trialists. Federation Nationale des Centres de Lutte Contre le Cancer. Int J Radiat Oncol Biol Phys 32 3 (1995) 651-659
39. Cesaretti J.A. Adjuvant radiation with modern techniques is the standard of care for stage III thymoma. Ann Thorac Surg 81 3 (2006) 1180-1181 [author reply: 1181-2]
40. Ogawa K., Toita T., Uno T., et al. Treatment and prognosis of thymic carcinoma: a retrospective analysis of 40 cases. Cancer 94 12 (2002) 3115-3119
41. Kaghad M., Bonnet H., Yang A., et al. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90 4 (1997) 809-819
42. Macchiarini P., Chella A., Ducci F., et al. Neoadjuvant chemotherapy, surgery, and postoperative radiation therapy for invasive thymoma. Cancer 68 4 (1991) 706-713
43. Huang J., Rizk N.P., Travis W.D., et al. Feasibility of multimodality therapy including extended resections in stage IVA thymoma. J Thorac Cardiovasc Surg 134 6 (2007) 1477-1483 [discussion: 1483-4]
44. Hsu H.C., Huang E.Y., Wang C.J., et al. Postoperative radiotherapy in thymic carcinoma: treatment results and prognostic factors. Int J Radiat Oncol Biol Phys 52 3 (2002) 801-805
45. Arriagada R., Bretel J.J., Caillaud J.M., et al. Invasive carcinoma of the thymus. A multicenter retrospective review of 56 cases. Eur J Cancer Clin Oncol 20 1 (1984) 69-74
46. Mayer R., Beham-Schmid C., Groell R., et al. Radiotherapy for invasive thymoma and thymic carcinoma. Clinicopathological review. Strahlenther Onkol 175 6 (1999) 271-278
47. Chahinian A.P. Chemotherapy of thymomas and thymic carcinomas. Chest Surg Clin N Am 11 2 (2001) 447-456
48. Loehrer Sr. P.J., Jiroutek M., Aisner S., et al. Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial. Cancer 91 11 (2001) 2010-2015
49. Weide L.G., Ulbright T.M., Loehrer Sr. P.J., et al. Thymic carcinoma. A distinct clinical entity responsive to chemotherapy. Cancer 71 4 (1993) 1219-1223
50. Maruyama R., Suemitsu R., Okamoto T., et al. Persistent and aggressive treatment for thymic carcinoma. Results of a single-institute experience with 25 patients. Oncology 70 5 (2006) 325-329
51. Kanda S., Koizumi T., Komatsu Y., et al. Second-line chemotherapy of platinum compound plus CPT-11 following ADOC chemotherapy in advanced thymic carcinoma: analysis of seven cases. Anticancer Res 27 4C (2007) 3005-3008
52. Komatsu Y., Koizumi T., Tanabe T., et al. Salvage chemotherapy with carboplatin and paclitaxel for cisplatin-resistant thymic carcinoma-three cases. Anticancer Res 26 6C (2006) 4851-4855
53. Eng T.Y., Fuller C.D., Jagirdar J., et al. Thymic carcinoma: state of the art review. Int J Radiat Oncol Biol Phys 59 3 (2004) 654-664
54. Hernandez-Ilizaliturri F.J., Tan D., Cipolla D., et al. Multimodality therapy for thymic carcinoma (TCA): results of a 30-year single-institution experience. Am J Clin Oncol 27 1 (2004) 68-72
55. Nakamura Y., Kunitoh H., Kubota K., et al. Platinum-based chemotherapy with or without thoracic radiation therapy in patients with unresectable thymic carcinoma. Jpn J Clin Oncol 30 9 (2000) 385-388
56. Loehrer Sr. P.J., Chen M., Kim K., et al. Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial. J Clin Oncol 15 9 (1997) 3093-3099
57. Koizumi T., Takabayashi Y., Yamagishi S., et al. ADOC regimen for unresectable advanced thymic cancer. Nihon Kokyuki Gakkai Zasshi 37 12 (1999) 970-973 [in Japanese]
58. Magois E., Guigay J., Blancard P.S., et al. Multimodal treatment of thymic carcinoma: report of nine cases. Lung Cancer 59 1 (2008) 126-132
59. Greene M.A., and Malias M.A. Aggressive multimodality treatment of invasive thymic carcinoma. J Thorac Cardiovasc Surg 125 2 (2003) 434-436
60. Latz D., Schraube P., Oppitz U., et al. Invasive thymoma: treatment with postoperative radiation therapy. Radiology 204 3 (1997) 859-864
61. Pollack A., Komaki R., Cox J.D., et al. Thymoma: treatment and prognosis. Int J Radiat Oncol Biol Phys 23 5 (1992) 1037-1043
62. Nonaka T., Tamaki Y., Higuchi K., et al. The role of radiotherapy for thymic carcinoma. Jpn J Clin Oncol 34 12 (2004) 722-726
63. Lucchi M., Mussi A., Basolo F., et al. The multimodality treatment of thymic carcinoma. Eur J Cardiothorac Surg 19 5 (2001) 566-569
64. Liu H.C., Hsu W.H., Chen Y.J., et al. Primary thymic carcinoma. Ann Thorac Surg 73 4 (2002) 1076-1081
65. Tseng Y.L., Wang S.T., Wu M.H., et al. Thymic carcinoma: involvement of great vessels indicates poor prognosis. Ann Thorac Surg 76 4 (2003) 1041-1045
66. Shimada K., Okada Y., Matsumura Y., et al. Assessment of mode of recurrence after surgical treatment for thymic carcinoma. Kyobu Geka 55 11 (2002) 976-980 [in Japanese]
67. Milano M.T., Constine L.S., and Okunieff P. Normal tissue tolerance dose metrics for radiation therapy of major organs. Semin Radiat Oncol 17 2 (2007) 131-140